| References
1. Naguib V. Biotherapeutic
potential of L. Acidophilus. Vitamin
Retailer 2001: 42-54.
2. Collins MD, Gibson
GR. Probiotics, prebiotics, and synbiotics: approaches for modulating the
microbial ecology of the gut. Am J Clin Nutr 1999;69(suppl): 1052-7S.
3. Mohan JC, Arora R,
Khalilullah M. Short-term hypolipidemic effects of oral Lactobacillus sporogenes
in patients with primary dyslipidemias. Indian Heart J 1990;42:361-364.
4. Hoolihan
LK. Prophylactic and therapeutic uses of probiotics: A review. J Am
Diet Assn 2001;101: 229-241.
5. Dodd HM, Gasson MJ.
Bacteriocins of lactic acid bacteria. In: Gasson MJ, de Vos WM, eds. Genetics
and biotechnology of lactic acid bacteria. Glasgow, United Kingdom: Blackie
Academic and Professional; 1994;:211-51.
6. Kailasapathy K, Chin
J. Survival and therapeutic potential of probiotic organisms with reference
to Lactobacillus Acidophilus and Bifidobacterium spp. Immunol Cell Biol
2000;78(1):80-8.
7. Langhendries JP, Detry
J, Van Hees J, Lamboray JM, Darimont J, Mozin MJ, Secretin MC, Senterre
J. Effect of a fermented infant formula containing viable bifidobacteria
on the fecal flora composition and pH of healthy full-term infants. J Pediatr
Gastroenterol Nutr 1995;21:177-81.
8. Isolauri E, Juntunen
M, Rautanen T, Sillanaukee P, Koivula T. A human Lactobacillus strain (Lactobacillus
casei sp. Strain GG) promotes recovery from acute diarrhea in children.
Pediatrics 1991;88:90-97.
9. Isolauri E, Joensuu
J, Suomalainen H, Luomala M, Vesikari T. Improved immunogenicity of oral
D 3 RRV reassortant rotavirus vaccine by Lactobacillus casei GG. Vaccine
1995;13:310-312.
10. Rolfe RD. The role
of probiotic cultures in the control of gastrointestinal health. J Nutr
2000;130(2S):396S-402S.
11. De Vuyst L, Vandamme
EJ. Antimicrobial potential of lactic acid bacteria. In: De Vuyst L, Vandamme
EJ, eds. Bacteriocins
of lactic acid bacteria: microbiology, genetics, and applications.
Glasgow, United Kingdom: Blackie Academic & Professional, 1994;:91-142.
12. Fujiwara S, Hashiba
H, Hirota T, Forstner JF. Proteinaceous factor(s) in culture supernatant
fluids of bifidobacteria which prevents the binding of entertoxigenic Escherichia
coli to gangliotetraosylceramide. App Environ Microbiol 1997;63:506-12.
13. Rombeau JL, Kripke
SA, Settle RG. Short-chain fatty acids. Production, absorption, metabolism
and intestinal effects. In: Kritchesvsky D, ed. Dietary fiber: chemistry,
physiology, and health effects. New York and London: Plenum Press; 1990;:317-337.
14. Rasic J. Antimicrobial
effect of Lactobacillus acidophilus and Lactobacillus delbrueckii susp.
bulgaricus against Helicobacter pylori in vitro. Gastroenteroloska SLD
1995;14(4):158-160.
15. Cresci GA. The use
of Probiotics with the treatment of diarrhea. Nutr in Clin Prac, Newsletter
2001;16:30-34.
16. Bengmark S, Jeppsson
B. Gastrointestinal surface protection and mucosa reconditioning. JPEN
1995;19:410-415.
|
